Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $368K | ﹤0.01% |
10,712
+4,712
| +79% | +$170K |
|
2802
Republic Bancorp
RBCAA
$1.86B
| $368K | ﹤0.01% |
+15,009
| New | +$376K |
|
|
CRAY
2803
DELISTED
Cray, Inc.
CRAY
| $368K | ﹤0.01% |
+18,559
| New | +$431K |
|
|
CCXI
2804
DELISTED
ChemoCentryx, Inc.
CCXI
| $367K | ﹤0.01% |
60,718
-11,428
| -16% | -$82.6K |
|
2805
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.8B
| $365K | ﹤0.01% |
+3,765
| New | +$391K |
|
|
CTG
2806
DELISTED
Computer Task Group, Inc.
CTG
| $365K | ﹤0.01% |
58,900
-16,447
| -22% | -$113K |
|
2807
York Water
YORW
$554M
| $363K | ﹤0.01% |
+17,290
| New | +$368K |
|
|
SHYF
2808
DELISTED
The Shyft Group
SHYF
| $362K | ﹤0.01% |
87,550
+16,880
| +24% | +$73.7K |
|
|
CORR
2809
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $362K | ﹤0.01% |
16,360
-54,750
| -77% | -$1.53M |
|
|
LNKD
2810
DELISTED
LinkedIn Corporation
LNKD
| $361K | ﹤0.01% |
+1,899
| New | +$377K |
|
|
MRCC
2811
DELISTED
Monroe Capital Corp
MRCC
| $360K | ﹤0.01% |
+25,919
| New | +$382K |
|
2812
Paycom
PAYC
$10.5B
| $360K | ﹤0.01% |
10,012
-144,840
| -94% | -$5.26M |
|
|
COL
2813
DELISTED
Rockwell Collins
COL
| $360K | ﹤0.01% |
+4,400
| New | +$378K |
|
|
SHLO
2814
DELISTED
Shiloh Industries Inc
SHLO
| $359K | ﹤0.01% |
44,352
+8,374
| +23% | +$92.7K |
|
2815
W.P. Carey
WPC
$16.3B
| $358K | ﹤0.01% |
6,323
-99,760
| -94% | -$5.81M |
|
|
PZE
2816
DELISTED
Petrobras Argentina S A
PZE
| $358K | ﹤0.01% |
70,089
-58,102
| -45% | -$356K |
|
2817
State Street SPDR S&P Biotech ETF
XBI
$11.8B
| $357K | ﹤0.01% |
+5,738
| New | +$452K |
|
|
SEMI
2818
DELISTED
SunEdison Semiconductor Limited
SEMI
| $356K | ﹤0.01% |
33,758
-117,299
| -78% | -$1.58M |
|
|
FISV
2819
Fiserv Inc
FISV
$28B
| $355K | ﹤0.01% |
8,206
-103,102
| -93% | -$4.46M |
|
|
SSRG
2820
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $355K | ﹤0.01% |
39,904
-8,276
| -17% | -$71.1K |
|
2821
First Bancorp
FBNC
$2.68B
| $354K | ﹤0.01% |
20,831
+6,862
| +49% | +$116K |
|
|
MFLX
2822
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $354K | ﹤0.01% |
21,200
-118,499
| -85% | -$2.06M |
|
2823
Curis
CRIS
$3.88M
| $352K | ﹤0.01% |
87
-71
| -45% | -$402K |
|
|
CPE
2824
DELISTED
Callon Petroleum Company
CPE
| $352K | ﹤0.01% |
+4,823
| New | +$374K |
|
2825
GoPro
GPRO
$110M
| $350K | ﹤0.01% |
11,198
+4,549
| +68% | +$224K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.